{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T07:14:31Z","timestamp":1789370071484,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Biochemistry & Cell Biology"],"published-print":{"date-parts":[[2007]]},"DOI":"10.1016\/j.biocel.2007.04.026","type":"journal-article","created":{"date-parts":[[2007,5,11]],"date-time":"2007-05-11T07:47:17Z","timestamp":1178869637000},"page":"1747-1753","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["The cellular origin of mantle cell lymphoma"],"prefix":"10.1016","volume":"39","author":[{"given":"Francesco","family":"Bertoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurilio","family":"Ponzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biocel.2007.04.026_bib1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/hon.767","article-title":"Update on the molecular biology of mantle cell lymphoma","volume":"24","author":"Bertoni","year":"2006","journal-title":"Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.biocel.2007.04.026_bib2","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1046\/j.1365-2141.2003.04761.x","article-title":"Molecular basis of mantle cell lymphoma","volume":"124","author":"Bertoni","year":"2004","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.biocel.2007.04.026_bib3","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1182\/blood.V99.1.238","article-title":"ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances","volume":"99","author":"Camacho","year":"2002","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.biocel.2007.04.026_bib4","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1182\/blood-2006-03-013821","article-title":"Protein tyrosine phosphatase receptor-type O truncated (PTPROt) regulates SYK phosphorylation, proximal B-cell-receptor signaling, and cellular proliferation","volume":"108","author":"Chen","year":"2006","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.biocel.2007.04.026_bib5","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1200\/JCO.2005.10.980","article-title":"Mantle cell lymphoma: At last, some hope for successful innovative treatment strategies","volume":"23","author":"Fisher","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"30","key":"10.1016\/j.biocel.2007.04.026_bib6","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1200\/JCO.2006.07.9665","article-title":"Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma","volume":"24","author":"Fisher","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"13","key":"10.1016\/j.biocel.2007.04.026_bib7","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1182\/blood-2005-04-1753","article-title":"Cyclin D1-negative mantle cell lymphoma: A clinicopathological study based on gene expression profiling","volume":"106","author":"Fu","year":"2005","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.biocel.2007.04.026_bib8","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1073\/pnas.0510441103","article-title":"Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma","volume":"103","author":"Greiner","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"9","key":"10.1016\/j.biocel.2007.04.026_bib9","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1200\/JCO.2003.09.057","article-title":"Flavopiridol in untreated or relapsed mantle-cell lymphoma: Results of a phase II study of the National Cancer Institute of Canada Clinical Trials Group","volume":"21","author":"Kouroukis","year":"2003","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.biocel.2007.04.026_bib10","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/annonc\/mdi217","article-title":"In vitro activity of cyclin-dependent kinase inhibitor CYC202 (Seliciclib, R-roscovitine) in mantle cell lymphomas","volume":"16","author":"Lacrima","year":"2005","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.biocel.2007.04.026_bib11","series-title":"The lymphomas","first-page":"391","article-title":"Mantle cell lymphoma","author":"Lenz","year":"2006"},{"key":"10.1016\/j.biocel.2007.04.026_bib12","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1182\/blood-2006-05-026203","article-title":"Syk-dependent mTOR activation in follicular lymphoma cells","volume":"108","author":"Leseux","year":"2006","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.biocel.2007.04.026_bib13","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1158\/1078-0432.CCR-05-2780","article-title":"Lack of methylthioadenosine phosphorylase expression in mantle cell lymphoma is associated with shorter survival: Implications for a potential targeted therapy","volume":"12","author":"Marce","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.biocel.2007.04.026_bib14","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1182\/blood-2006-04-016634","article-title":"Mantle cell lymphoma cells express predominantly cyclin D1a isoform and are highly sensitive to selective inhibition of CDK4 kinase activity","volume":"108","author":"Marzec","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.biocel.2007.04.026_bib15","doi-asserted-by":"crossref","unstructured":"Park, I. W., Reddy, M. V., Reddy, E. P., & Groopman, J. E. (2007). Evaluation of novel cell cycle inhibitors in mantle cell lymphoma. Oncogene, in press.","DOI":"10.1038\/sj.onc.1210350"},{"issue":"6","key":"10.1016\/j.biocel.2007.04.026_bib16","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.2353\/ajpath.2006.051078","article-title":"Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma","volume":"169","author":"Peponi","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biocel.2007.04.026_bib17","doi-asserted-by":"crossref","unstructured":"Pinyol, M., Bea, S., Pla, L., Ribrag, V., Bosq, J., Rosenwald, A., et al. (2007). Inactivation of RB1 in mantle cell lymphoma detected by nonsense-mediated mRNA decay pathway inhibition and microarray analysis. Blood, in press.","DOI":"10.1182\/blood-2006-11-057208"},{"key":"10.1016\/j.biocel.2007.04.026_bib18","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2141.2005.05883.x","article-title":"Genomic and expression profiling identifies the B cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma","volume":"132","author":"Rinaldi","year":"2006","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.biocel.2007.04.026_bib19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1535-6108(03)00028-X","article-title":"The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma","volume":"3","author":"Rosenwald","year":"2003","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.biocel.2007.04.026_bib20","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1182\/blood-2006-04-015586","article-title":"Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma","volume":"108","author":"Rudelius","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.biocel.2007.04.026_bib21","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1200\/JCO.2006.08.4251","article-title":"Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature","volume":"25","author":"Salaverria","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biocel.2007.04.026_bib22","series-title":"World Health Organization classification of tumours. pathology and genetics of tumours of haematopoietic and lymphoid tissues","first-page":"168","article-title":"Mantle cell lymphoma","author":"Swerdlow","year":"2001"},{"issue":"1","key":"10.1016\/j.biocel.2007.04.026_bib23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2141.2005.05716.x","article-title":"Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): A clinicopathological study from the European MCL Network","volume":"131","author":"Tiemann","year":"2005","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.biocel.2007.04.026_bib24","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1385\/MO:22:4:327","article-title":"Immunoglobulin gene analysis of mature B-cell malignancies: reconsideration of cellular origin and potential antigen involvement in pathogenesis","volume":"22","author":"Walsh","year":"2005","journal-title":"Med. Oncol."},{"key":"10.1016\/j.biocel.2007.04.026_bib25","series-title":"Malignant lymphoma","first-page":"27","article-title":"Mantle cell lymphoma","author":"Weisenburger","year":"2000"},{"key":"10.1016\/j.biocel.2007.04.026_bib26","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.1182\/blood-2006-08-039859","article-title":"Point mutations and genomic deletions in Cyclin D1 create stable truncated mRNAs that are associated with increased proliferation rate and shorter survival in mantle cell lymphoma","volume":"109","author":"Wiestner","year":"2007","journal-title":"Blood"},{"issue":"26","key":"10.1016\/j.biocel.2007.04.026_bib27","doi-asserted-by":"crossref","first-page":"6409","DOI":"10.1200\/JCO.2005.55.017","article-title":"Current treatment approaches for mantle-cell lymphoma","volume":"23","author":"Witzig","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"23","key":"10.1016\/j.biocel.2007.04.026_bib28","doi-asserted-by":"crossref","first-page":"5347","DOI":"10.1200\/JCO.2005.13.466","article-title":"Phase II trial of single-agent temsirolimus (CCI-779) for relapsed mantle cell lymphoma","volume":"23","author":"Witzig","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"17","key":"10.1016\/j.biocel.2007.04.026_bib29","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1158\/1078-0432.CCR-06-0764","article-title":"Phase I\/II study of the mammalian target of rapamycin inhibitor everolimus (RAD001) in patients with relapsed or refractory hematologic malignancies","volume":"12","author":"Yee","year":"2006","journal-title":"Clin. Cancer Res."}],"container-title":["The International Journal of Biochemistry & Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272507001410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272507001410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T06:27:55Z","timestamp":1761200875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1357272507001410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007]]}},"alternative-id":["S1357272507001410"],"URL":"https:\/\/doi.org\/10.1016\/j.biocel.2007.04.026","relation":{},"ISSN":["1357-2725"],"issn-type":[{"value":"1357-2725","type":"print"}],"subject":[],"published":{"date-parts":[[2007]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The cellular origin of mantle cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"The International Journal of Biochemistry & Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biocel.2007.04.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}